Validation Sampling Plans, Setting Acceptance Specifications and Statistical Process Control

This webinar will cover designing sampling plans for process and test method validation and using those sampling plans to set acceptance criteria. A discussion of statistical process controls will help ensure you stay in a validated state.

Webinar Oct 09 2025, Thursday 01:30 PM EDT 60 Minutes Advance Level Code: GRC0000166

This workshop will explore the topic of setting appropriate sampling plans and using those plans to set appropriate acceptance criteria for process validations. Using a 5 step method, the attendee will come away with a good understanding of sampling for validation including using risk to make sampling decisions. It will also explore using variance to set acceptance criteria for test method validation. Lastly, we will take a look at using statistical process controls to ensure our process is maintained in a validated and controlled state.

  • What is sampling?
  • Validation sampling vs. lot acceptance sampling
  • Setting up a validation sampling plan 5-step method
  • Using sampling plans to set acceptance criteria for process validations
  • Setting acceptance criteria for test method validation
  • Variance: How much is too much?
  • How to measure variance and why?
  • Use of process capability to set acceptance criteria
  • Statistical process control and maintaining a controlled state

R&D scientists involved in method validation, validation quality, validation engineers, manufacturing, and quality control teams involved in invalidations.

Proper validation of processes and test methods is required by regulations for all pharmaceutical and medical device manufacturers. Setting appropriate sampling and acceptance criteria is essential to successful validation.

ALAN GOLDEN
ALAN GOLDEN
35 years of experience in the medical device industry, both in basic research and quality assurance.

Alan has over 35 years of experience in the medical device industry, both in basic research and quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents and published numerous papers and abstracts. Alan then transitioned to a quality assurance role where in both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support and operations.

  • 90 Mins | Dec 31, Wed , 01:00 PM EDT

This live interactive presentation will also discuss the regulations associated with the detection, correction, and prev...

ALAN GOLDEN By ALAN GOLDEN

  • Dec 26, Friday | 01:00 PM EDT | 75 Mins

“The future belongs to individuals and companies who embrace the entrepreneurial spirit, whether that is inside or...

  • Dec 26, Friday | 02:00 PM EDT | 120 Mins

A properly-composed JHA/AHA is one of the primary documents that large clients are increasingly asking to review in adva...

  • Dec 26, Friday | 03:00 PM EDT | 90 Mins

Skills-based hiring has been a topic of interest for many businesses and governments for the past few years. But even as...